The most significant upward adjustment over the last 14 days belongs to UnitedHealth Group (UNH), where Leerink Partners hiked its target from $400 to $462 on June 17. This shift stands out in a market where volatility in target pricing remains concentrated in select sectors. As of the June 18, 2026, data-as-of timestamp, the contrast between UNH’s bullish revision and the collective downward sentiment surrounding Adobe (ADBE) defines the current reporting cycle.
The week in PT changes
The surge of attention around ROKU has been impossible to miss. Five firms—Loop Capital, Piper Sandler, Susquehanna, JP Morgan, and Rosenblatt—all moved to establish or lift their targets to $160, even as Evercore ISI Group took a contrarian view, lowering its target to $160 from $185. This clustering suggests institutional analysts are recalibrating their models to a tighter consensus range for the streaming provider.
| Ticker | Firm | Dir | Prior→Current |
|---|---|---|---|
| UNH | Leerink Partners | up | 400→462 |
| TXN | Citigroup | up | 280→345 |
| ADBE | JP Morgan | down | 420→340 |
| PEP | Piper Sandler | down | 181→178 |
Elsewhere, the IT sector saw a massive divergence in sentiment. While Citigroup pushed its TXN target to $345, the broader story for ADBE was a severe, sector-wide reset. Between June 12 and June 16, a dozen major shops, including Goldman Sachs, UBS, and Wells Fargo, slashed their targets for the software giant, with JP Morgan’s $80 cut from $420 to $340 representing the most aggressive single-firm reduction in that cohort. Investors looking for a detailed breakdown of these shifts can explore our latest target revisions.
What the data does not say
These figures are snapshots of analyst sentiment at specific moments in time, not indicators of future price performance. For instance, the uniform $47 upside figure appearing across the ADBE downgrade list is a byproduct of the mathematical relationship between the firm’s current market price and the revised consensus, rather than a coordinated analyst prediction. Furthermore, while TXN received a notable upgrade to $345, the current consensus mean is actually lower than that mark, signaling that Citigroup’s outlook remains more optimistic than the general average of their peers. Finally, the absence of downgrades in the energy or healthcare sectors within this dataset does not imply a lack of bearish sentiment; it simply highlights where the most active revision activity has been centered over the past two weeks.